Ally Bridge Group (NY) LLC - BOLT BIOTHERAPEUTICS INC ownership

BOLT BIOTHERAPEUTICS INC's ticker is BOLT and the CUSIP is 097702104. A total of 73 filers reported holding BOLT BIOTHERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
Ally Bridge Group (NY) LLC ownership history of BOLT BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2021$3,254,000
-48.9%
257,267
-37.6%
0.96%
-39.6%
Q2 2021$6,374,000
-32.7%
412,267
+43.3%
1.58%
-12.7%
Q1 2021$9,469,000287,7251.82%
Other shareholders
BOLT BIOTHERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Pivotal bioVenture Partners Investment Advisor LLC 1,891,467$5,183,0002.45%
Nan Fung Group Holdings Ltd 1,166,952$3,197,0001.52%
Vivo Capital, LLC 3,871,291$10,607,0000.73%
Samsara BioCapital, LLC 1,049,153$2,875,0000.72%
Novo Holdings A/S 4,503,991$12,341,0000.65%
Sofinnova Investments, Inc. 2,754,437$7,547,0000.57%
Hawkeye Capital Management, LLC 415,039$1,137,0000.45%
SUVRETTA CAPITAL MANAGEMENT, LLC 2,230,250$6,111,0000.19%
Board of Trustees of The Leland Stanford Junior University 719,546$1,972,0000.11%
Echo Street Capital Management LLC 123,804$5,493,0000.04%
View complete list of BOLT BIOTHERAPEUTICS INC shareholders